Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00703963 · ClinicalTrials.gov registry record · NA
Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT00703963: Completed NA study, sponsored by Mayo Clinic.
NCT00703963 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00703963, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
Patients who receive a mechanical heart valve to replace a diseased heart valve must take an anticoagulation medicine the rest of their lives, and monitor their level of anticoagulation. Until recently, the testing of the level of anticoagulation was performed at medical laboratories or hospitals. The purpose of this study is to see if patients who test their level of anticoagulation by themselves at home and then call their doctor with the result have better control of their anticoagulation as compared to patients whose anticoagulation is checked only by their physician.
Interventions
- OTHER Usual Care
- DEVICE INRatio monitor by Hemosense
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-03 |
| Phase | NA |
What the finished NCT00703963 record still lists
NCT00703963 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT00703963 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00703963 about?
NCT00703963 is a clinical study titled "Improved Time in Therapeutic Range With Patient Self-Testing of Their INR Compared to Usual Care". Patients who receive a mechanical heart valve to replace a diseased heart valve must take an anticoagulation medicine the rest of their lives, and monitor their level of anticoagulation. Until recently, the testing of the level of anticoagulation was performed at medical laboratories or hospitals. ...
What is the current status of trial NCT00703963?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2007-03. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00703963?
The interventions under investigation include: Usual Care (OTHER), INRatio monitor by Hemosense (DEVICE).
Who is sponsoring clinical trial NCT00703963?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00703963's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia